Title : Phase I study of nanoparticle albumin-bound paclitaxel, carboplatin and trastuzumab in women with human epidermal growth factor receptor 2-overexpressing breast cancer.

Pub. Date : 2017 Apr

PMID : 28413662

1 Functional Relationships(s)
Compound Name
Protein Name
1 Based on these results, a phase I study of combination therapy with nab-paclitaxel, carboplatin and trastuzumab was planned, in order to estimate its efficacy and safety for HER2-overexpressing locally advanced breast cancer. nab erb-b2 receptor tyrosine kinase 2 Homo sapiens